Drug reference
nitrendipine
Dihydropyridine calcium channel blocker · Antianginal
Dihydropyridine calcium channel blockerAntianginal
CDSCO approved
EXCRETION
—
not curated
INTERACTIONS
—
none in our sources
PREGNANCY
—
not curated
Mechanism
Releases NO from the endothelium and inhibits cAMP phosphodiesterase, contributing to vasodilator action. The endothelial NO may retard atherosclerosis. Does not depress ventricular contractility and A-V conduction.
Indications
HypertensionAngina pectoris
Dosing
- Adult
- 5–20 mg OD
Pharmacokinetics
Half-life
4–12 hours
Bioavailability
10–30%
Drug interactions
1 additional unreviewed or low-confidence interaction hidden because their provenance or source detail is insufficient.
Related guidelines
Other Dihydropyridine calcium channel blocker drugs
Ask House about nitrendipine
Continue into a citation-backed clinical answer with the drug context already attached.
Textbook-sourced·Sources: KD Tripathi 7e·Updated: 2026-05-10